StockData
IRIDEX Corp logo

IRIDEX Corp (IRIX) stock

IRIXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 17, 2026Score 8/30
$0.70+0.01 (+1.72%)

Close on Nov 17, 2026Market cap $12.29MP/E –Yield –

Iridex price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Iridex's price to sales ratio was 0.2× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.2× to 1.9×, with a median of 0.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−0.2
2025Dec 31, 20250.4×−0.2
2024Dec 31, 20240.6×−0.3
2023Dec 29, 20230.8×+0.3
2022Dec 30, 20220.6×−1.3
2021Dec 31, 20211.9×+0.9
2020Dec 31, 20201.0×+0.3
2019Dec 31, 20190.7×−0.8
2018Dec 31, 20181.5×−0.5
2017Dec 29, 20172.0×−1.1
2016Dec 30, 20163.1×+0.9
2015Dec 31, 20152.2×+0.2
2014Dec 31, 20142.0×−0.7
2013Dec 31, 20132.7×+1.7
2012Dec 31, 20121.1×−0.3
2011Dec 30, 20111.3×+0.1
2010Dec 31, 20101.3×–

More Iridex figures

See a number that looks wrong?